Exact Sciences
EXAS
#1852
Rank
C$12.78 B
Marketcap
$68.85
Share price
0.30%
Change (1 day)
-14.19%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -C$1.45 Billion

According to Exact Sciences's latest financial reports the company's current earnings are C$2.75 Billion. a decrease over its 2023 earnings that were of -C$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -C$1.48 Billion435.08%
2023 -C$0.28 Billion-69.28%
2022 -C$0.9 Billion-25.55%
2021 -C$1.21 Billion1.68%
2020 -C$1.19 Billion271.17%
2019 -C$0.32 Billion58.99%
2018 -C$0.21 Billion20.89%
2017 -C$0.17 Billion-30.95%
2016 -C$0.24 Billion5.09%
2015 -C$0.23 Billion57.24%
2014 -C$0.15 Billion116.53%
2013 -C$67.04 Million
2011 -C$41.74 Million143.73%
2010 -C$17.13 Million27.85%
2009 -C$13.4 Million0.27%
2008 -C$13.36 Million-20.95%
2007 -C$16.9 Million-13.53%
2006 -C$19.55 Million-10.07%
2005 -C$21.73 Million-21.81%
2004 -C$27.8 Million-33.44%
2003 -C$41.76 Million-6.51%
2002 -C$44.66 Million17.95%
2001 -C$37.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.17 Billion-88.81%๐Ÿ‡บ๐Ÿ‡ธ USA
C$95.38 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.83 Million-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$50.63 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.49 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France